Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

663
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
663

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel approach to radioembolization treatment planning using a hybrid [<sup>99m</sup>Tc]Tc-MAA contrast enhanced SPECT/CT.

European journal of nuclear medicine and molecular imaging·2026
Same author

Radioligand therapy for paediatric patients with solid tumours.

The British journal of radiology·2026
Same author

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

The Lancet. Oncology·2026
Same author

European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine.

The Lancet. Oncology·2026
Same author

Fraction-dependent dose dynamics and clinical safety in high-risk neuroblastoma treated with [<sup>177</sup>Lu]Lu-DOTATATE: results from the LuDO-N trial.

European journal of nuclear medicine and molecular imaging·2026
Same author

Diagnostic Imaging Modalities for Vascular Thoracic Outlet Syndrome: A Topical Review and Proposed Diagnostic Pathway.

Annals of vascular surgery·2026

Related Experiment Video

Updated: Apr 12, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.5K

⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments.

Arthur J A T Braat1, Maarten L J Smits2, Manon N G J A Braat1

  • 1Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Heidelberglaan, Utrecht, The Netherlands a.j.a.t.braat@umcutrecht.nl.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|May 9, 2015
PubMed
Summary

This review covers recent advancements in radioembolization, a liver cancer treatment. It discusses patient selection, treatment techniques, and future applications for improved outcomes.

Keywords:
90Ydosimetryhepatic vasculatureliver malignanciesradioembolization

More Related Videos

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.4K
Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.9K

Related Experiment Videos

Last Updated: Apr 12, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.5K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.4K
Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.9K

Area of Science:

  • Interventional Radiology
  • Oncology
  • Nuclear Medicine

Background:

  • Radioembolization is a widely used treatment for liver tumors.
  • Significant advancements have been made in radioembolization techniques over the past decade.
  • These developments impact patient selection and treatment protocols.

Purpose of the Study:

  • To provide a comprehensive overview of current radioembolization practices.
  • To highlight recent innovations and developments in the field.
  • To offer practical recommendations for radioembolization application.

Main Methods:

  • Review of current literature and clinical practices in radioembolization.
  • Analysis of recent technological and procedural advancements.
  • Discussion of practical considerations from patient selection to treatment response.

Main Results:

  • Radioembolization is evolving rapidly with new techniques and improved patient selection criteria.
  • Practical challenges in radioembolization are being addressed through ongoing research and development.
  • Emerging applications suggest a growing role for radioembolization in liver cancer management.

Conclusions:

  • Radioembolization remains a dynamic field with continuous improvements.
  • Understanding recent developments is crucial for optimizing patient care and treatment outcomes.
  • Future research will likely focus on expanding applications and refining existing techniques.